Why Direct-to-Consumer Prescription Medicine Export Is Illegal — and What Actually Works
The single fact that shapes every legitimate pharmaceutical export business, and why this platform is built as a B2B quotation system rather than a checkout.
An Indian website that takes an order from an individual consumer abroad and ships them prescription medicine is not operating in a grey area — it is drug importation without approval at the destination, and in the US it has produced criminal convictions of India-based web pharmacy operators. Personal-importation enforcement discretion, sometimes cited as a loophole, exists to protect individual patients in narrow circumstances and explicitly excludes any commercialised storefront. Controlled substances have no personal-use exception at all.
What this changes — and what it doesn't
None of this stops legitimate export from India. It changes who a compliant exporter sells to. The legal, large route is B2B: selling to licensed importers, wholesalers, hospital groups, government tenders and registered pharmacy chains abroad, each of whom holds the import authorisation in their own country and carries the onward compliance obligation. This is why India Pharma Export operates as a quotation and sourcing platform — 'Request a Quote', not 'Buy Now' — and why we ask buyers to confirm their licence status rather than accepting anonymous consumer orders.
The exception: categories with no drug-registration requirement
Even there, we keep prescription and hospital-only lines on the same B2B quotation and bulk-supply model. For the nutraceuticals and AYUSH exception specifically, we do run a lightweight direct-order flow (add to cart, submit an order request) rather than a full consumer checkout — no online payment is collected, and every order is confirmed manually by our team before an invoice or bank-transfer request goes out. It is closer to an order form than a storefront, and it never extends to anything requiring a prescription.